Immuneering (IMRX) Current Assets (2020 - 2026)
Immuneering (IMRX) reported Current Assets of $150.71 million for Q3 2026, down 34.2% from $229.1 million a year earlier and down 4.6% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Immuneering posted Current Assets of $176.25 million, up 345.2% from FY2024.
- Current Assets has a five-year compound annual growth rate of 36.1% (FY2020 to FY2025).
- By year, Current Assets came in at $39.59 million in FY2024 (-55.6%), $89.08 million in FY2023 (-18.1%), $108.75 million in FY2022 (-28.6%) and $152.33 million in FY2021 (+303.7%).
- The Q3 2026 figure ranks as the lowest quarterly Current Assets since Q2 2025.
- Year over year, Current Assets gained in four of the last eight quarters, with growth averaging 157.1%.
- The high point for year-over-year Current Assets in five years was Q2 2026 (growth of 469.8%); the low point was Q2 2025 (a decline of 56.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $157.99 million (Q2 2026), $161.41 million (Q1 2026) and $176.25 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | 150.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 150.71 Mn |
| Jun 30, 2026 | 157.99 Mn |
| Mar 31, 2026 | 161.41 Mn |
| Dec 31, 2025 | 176.25 Mn |
| Sep 30, 2025 | 229.10 Mn |
| Jun 30, 2025 | 27.73 Mn |
| Mar 31, 2025 | 38.21 Mn |
| Dec 31, 2024 | 39.59 Mn |
| Sep 30, 2024 | 55.26 Mn |
| Jun 30, 2024 | 63.69 Mn |
| Mar 31, 2024 | 74.45 Mn |
| Dec 31, 2023 | 89.08 Mn |
| Sep 30, 2023 | 100.58 Mn |
| Jun 30, 2023 | 111.51 Mn |
| Mar 31, 2023 | 94.23 Mn |
| Dec 31, 2022 | 108.75 Mn |
| Sep 30, 2022 | 120.02 Mn |
| Jun 30, 2022 | 129.17 Mn |
| Mar 31, 2022 | 139.53 Mn |
| Dec 31, 2021 | 152.33 Mn |
API Access
Immuneering Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();